Interestingly, serum PCSK9 levels did not correlate with most of the conventional markers of liver injury, indicating that their elevation in autoimmune liver diseases is unlikely to result from hepatocellular damage alone. This evidence concerns the gene PCSK9 and autoimmune hepatitis.